|
Boulder, Colo., Biotechs Bet Human Genome Project Will Profit.
From:
Knight Ridder/Tribune Business News
| Date:
October 30, 1998| Author:
Daily Camera, Boulder, Colo.
| COPYRIGHT 1998 Knight-Ridder/Tribune Business News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Knight Ridder/Tribune Business News
Oct. 31--"All human disease is genetic in origin." -Dr. Paul Berg, Nobel laureate of Stanford University.
Life will never be the same.
The unraveling of the human genome -- the total of all the genes in our 43 chromosomes -- is bound to transform medicine. For businesses planning to commercialize information flowing from the Human Genome Project, it's bound to be lucrative -- if they're willing to make the long-t...
Related newspaper, magazine, and journal articles from HighBeam Research